We are live on ! Find out more
TELA icon

TELA Bio
TELA

49 hedge funds and large institutions have $126M invested in TELA Bio in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 19 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

850% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 2

350% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 6

149% more capital invested

Capital invested by funds: $50.7M → $126M (+$75.5M)

69% more funds holding

Funds holding: 29 → 49 (+20)

10.63% more ownership

Funds ownership: 56.93% → 67.56% (+11%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
49
Holders Change
+20
Holders Change %
+68.97%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
19
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$6.93M
2
SAM
Silvercrest Asset Management
New York
+$4.27M
3
EWM
Essex Woodlands Management
Texas
+$4.17M
4
BlackRock
BlackRock
New York
+$3.31M
5
SMH
Sanders Morris Harris
Texas
+$3.23M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$1.3M
2
WP
Woodline Partners
California
-$315K
3
CS
Credit Suisse
Switzerland
-$161K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$161K
5
DTL
Dynamic Technology Lab
Singapore
-$106K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$39.2M – – –
EWM
2
Essex Woodlands Management
Texas
$18M +$4.17M +317,537 +30%
RI
3
RTW Investments
New York
$17.7M +$2.96M +225,000 +20%
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$9.39M +$6.93M +527,391 +267%
CAC
5
Cowen and Company
New York
$5.31M +$51.4K +3,910 +1%
SAM
6
Silvercrest Asset Management
New York
$4.21M +$4.27M +325,000 New
PCM
7
Pentwater Capital Management
Florida
$3.6M +$2.81M +214,208 +338%
BlackRock
8
BlackRock
New York
$3.44M +$3.31M +252,045 +1,900%
SMH
9
Sanders Morris Harris
Texas
$3.43M +$3.23M +246,000 +1,337%
OM
10
Opaleye Management
Massachusetts
$3.24M +$2.22M +169,000 +209%
Vanguard Group
11
Vanguard Group
Pennsylvania
$3.15M +$2.53M +192,692 +385%
LM
12
Luminus Management
Texas
$2.45M +$2.48M +188,992 New
SSA
13
Schonfeld Strategic Advisors
New York
$2.02M +$1.62M +123,030 +375%
CH
14
CVI Holdings
Delaware
$1.47M +$1.48M +113,043 New
MAG
15
Millrace Asset Group
Pennsylvania
$1.18M +$1.2M +91,354 New
CCM
16
CAAS Capital Management
New York
$972K +$985K +75,000 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$841K +$457K +34,767 +115%
Citadel Advisors
18
Citadel Advisors
Florida
$809K +$636K +48,449 +347%
State Street
19
State Street
Massachusetts
$797K +$808K +61,513 New
Nomura Holdings
20
Nomura Holdings
Japan
$675K +$657K +50,000 New
PNC Financial Services Group
21
PNC Financial Services Group
Pennsylvania
$611K +$620K +47,179 New
EI
22
EAM Investors
California
$585K +$593K +45,177 New
Millennium Management
23
Millennium Management
New York
$562K -$23.8K -1,812 -4%
WMSA
24
Weiss Multi-Strategy Advisers
New York
$285K +$289K +22,000 New
ECM
25
ExodusPoint Capital Management
New York
$280K +$283K +21,570 New
1
2 3

TELA Hedge Fund Activity: Q2 2020 in Review

49 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q2 2020, worth a combined $126M — up 149% from $50.7M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TELA positions and 6 closed out — a net gain of 21 holders — while 19 added to existing stakes and 2 trimmed.

The largest buyer was Alyeska Investment Group, adding an estimated $6.93M. The largest seller was Federated Hermes, exiting entirely with an estimated $1.3M sold.

  • 49 institutional investors held TELA Bio (TELA) as of Q2 2020, up from 29 in Q1 2020.
  • Funds reported $126M of TELA Bio stock for Q2 2020, up 149% quarter-over-quarter.
  • 27 funds opened new TELA Bio positions in Q2 2020 and 6 closed out, a net change of +21 holders.
  • The largest TELA Bio buyer in Q2 2020 was Alyeska Investment Group, an estimated $6.93M added.
  • The largest TELA Bio seller in Q2 2020 was Federated Hermes, an estimated $1.3M sold.

Based on aggregated 13F filings for Q2 2020.